SCHEMBL1735119

SCHEMBL1735119

O=C1c2cccc(Cl)c2C(=O)N1c1ccc(N2C(=O)c3cccc(Cl)c3C2=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
HSPA1A P0DMV8 1/20 0.56
PABPC1 P11940 1/20 0.56
ADORA2A P29274 1/20 0.56
GRM1 Q13255 1/20 0.54
GRM4 Q14833 1/20 0.54
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
AHR P35869 1/20 0.47
NPC1 O15118 1/20 0.46
USP2 O75604 1/20 0.46
RAB9A P51151 1/20 0.46
ATM Q13315 1/20 0.46
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA9 Q16790 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20490838 0.95 MEN1 (0.53) MEN1KMT2AHSPA1APABPC1ADORA2A
SCHEMBL1500541 0.93 HSPA1A (0.67) MEN1KMT2AHSPA1APABPC1ADORA2A
SCHEMBL9453251 0.92 MEN1 (0.50) MEN1KMT2AHSPA1APABPC1ADORA2A
SCHEMBL9453245 0.92 HSPA1A (0.57) MEN1KMT2AHSPA1APABPC1ADORA2A
SCHEMBL17187939 0.90 HPGD (0.56) MEN1KMT2AHSPA1APABPC1ADORA2A
SCHEMBL1736347 0.89 HSPA1A (0.53) MEN1KMT2AHSPA1APABPC1GRM1
SCHEMBL16754922 0.89 CA1 (0.50) MEN1KMT2AHSPA1APABPC1ADORA2A
SCHEMBL2892449 0.87 MEN1 (0.58) MEN1KMT2AHSPA1APABPC1ADORA2A
SCHEMBL13323538 0.87 KMT2A (0.54) MEN1KMT2AHSPA1APABPC1ADORA2A
SCHEMBL2890258 0.86 HSPA1A (0.54) MEN1KMT2AHSPA1APABPC1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7714095-B2 Phase transfer catalyzed method for preparation of polyetherimides SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-05-11 US claimed
US-7481959-B2 Method for controlling haze in an article comprising a polymer composition SABIC INNOVATIVE PLASTICS IP B.V. (US) 2009-01-27 US claimed
EP-1989246-A2 PHASE TRANSFER CATALYZED METHOD FOR PREPARATION OF POLYETHERIMIDES Sabic Innovative Plastics IP B.V. (NL) 2008-11-12 EP claimed
WO-2007100473-A2 PHASE TRANSFER CATALYZED METHOD FOR PREPARATION OF POLYETHERIMIDES SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2007-09-07 WO claimed
EP-1805265-A1 METHOD FOR CONTROLLING HAZE IN AN ARTICLE COMPRISING A POLYMER COMPOSITION General Electric Company (US) 2007-07-11 EP claimed
US-20060173158-A1 Phase transfer catalyzed method for preparation of polyetherimides GENERAL ELECTRIC COMPANY (US) 2006-08-03 US claimed
WO-2006039160-A1 METHOD FOR CONTROLLING HAZE IN AN ARTICLE COMPRISING A POLYMER COMPOSITION GENERAL ELECTRIC COMPANY (US) 2006-04-13 WO claimed
US-20060066004-A1 Method for controlling haze in an article comprising a polymer composition GENERAL ELECTRIC COMPANY 2006-03-30 US claimed
US-6790934-B2 VIA CATALYTIC POLYMERIZATION IN PRESENCE OF WATER-IMMISCIBLE SOLVENT; EXTRACTION; FILTRATION GENERAL ELECTRIC COMPANY 2004-09-14 US claimed
US-20020151675-A1 Method for purification of aromatic polyethers SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2002-10-17 US claimed
EP-1233997-A1 METHOD FOR PURIFICATION OF AROMATIC POLYETHERS GENERAL ELECTRIC COMPANY (US) 2002-08-28 EP claimed
WO-2001021686-A1 METHOD FOR PURIFICATION OF AROMATIC POLYETHERS GENERAL ELECTRIC COMPANY (US) 2001-03-29 WO claimed
EP-3131949-B1 METHODS OF MANUFACTURE OF POLYETHERIMIDES SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-01-30 EP disclosed
EP-2162457-B1 CARBAZOLYL POLYMERS FOR ORGANIC ELECTRONIC DEVICES BOE TECHNOLOGY GROUP CO LTD (CN) 2018-08-22 EP disclosed
EP-3131949-A1 METHODS OF MANUFACTURE OF POLYETHERIMIDES SABIC Global Technologies B.V. (NL) 2017-02-22 EP disclosed
US-20170029567-A1 METHODS OF MANUFACTURE OF POLYETHERIMIDES SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-02-02 US disclosed
US-6790934-B2 VIA CATALYTIC POLYMERIZATION IN PRESENCE OF WATER-IMMISCIBLE SOLVENT; EXTRACTION; FILTRATION GENERAL ELECTRIC COMPANY 2004-09-14 US disclosed
EP-1233997-B1 METHOD FOR PURIFICATION OF AROMATIC POLYETHERS GEN ELECTRIC (US) 2003-09-03 EP disclosed
US-20020151675-A1 Method for purification of aromatic polyethers SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2002-10-17 US disclosed
US-6265521-B1 USING ALKALI METAL SALT OF A DIHYDROXY-SUBSTITUTED AROMATIC HYDROCARBON GENERAL ELECTRIC COMPANY 2001-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173158-A1 Phase transfer catalyzed method for preparation of polyetherimides TRRAP, RCC1, DDT MEN1 4568/4885KMT2A 326/4885HSPA1A 2941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.